ALUNBRIG 180MG TABLET

Form: Tablets

Pack Size: 28 TABLETS

Marketed by: TAKEDA BIOPHARMACEUTICALS INDIA PVT LTD (ONCOLOGY DIV)

MRP: ₹201213.00

TAKEDA BIOPHARMACEUTICALS INDIA PVT LTD (ONCOLOGY DIV): Alunbrig 180MG Tablet, 28 tablets, salt brigatinib 180mg. Its MRP stays at Rs 201,213 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 153,305.14. Group: ALK inhibitor (targeted therapy). No other manufacturer of this salt and strength is listed here yet. Handling/counselling: started at a lower lead-in strength; confirm which strength the patient is on. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.